Risk perceptions and health care use in the era of the COVID-19 pandemic in adults treated for childhood cancer.

COVID-19 Childhood cancer survivors Chronic health conditions Forgoing care Health care use Pandemic Risk perception Teleconsultation use

Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 03 02 2022
accepted: 03 04 2022
pubmed: 24 4 2022
medline: 31 5 2022
entrez: 23 4 2022
Statut: ppublish

Résumé

During the COVID-19 pandemic, childhood cancer survivors (CCS) may have felt more at risk of having severe consequences of COVID-19 and therefore may have been more likely to defer their health care use. We aimed to assess the risk perceptions of CCS related to COVID-19 (perceived infection risk, perceived risk of experiencing a severe illness in the event of infection), and their forgoing of health care during the year 2020. In December 2020, we interviewed through an online self-report questionnaire 580 5-year CCS participating in the French Childhood Cancer Survivor Study (FCCSS) cohort. Combining clinical and patient-reported outcomes, we studied predictors of perceived risks related to COVID-19 and forgoing health care. Overall, 60% of respondents stated that COVID-19 could have severe consequences for their health if infected. Survivors with a cardiovascular disease and those who felt more at risk of being infected were more likely to think that COVID-19 could have severe health consequences for them. Moreover, 30% of respondents seeking care declared they had forgone at least one medical appointment in 2020. Forgoing medical appointments was more common among CCS who reported a deterioration in their financial situation in 2020 and those who felt more at risk of being infected. This study shows that a considerable proportion of survivors had forgone medical appointments because of the pandemic; forgoing care was more frequent among the most socioeconomically disadvantaged survivors. This study presents data hitherto absent in the literature and suggests the need to develop telehealth to ensure appropriate long-term follow-up of CCS.

Identifiants

pubmed: 35460426
doi: 10.1007/s00520-022-07035-0
pii: 10.1007/s00520-022-07035-0
pmc: PMC9033518
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6263-6271

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

WHO (2020) Coronavirus disease 2019 (COVID-19): situation report, 51.
Sandford A (2020) Coronavirus: half of humanity on lockdown in 90 countries. In: Euronews. https://www.euronews.com/2020/04/02/coronavirus-in-europe-spain-s-death-toll-hits-10-000-after-record-950-new-deaths-in-24-hou . Accessed 9 Aug 2021
Lancet T (2020) COVID-19: learning from experience. Lancet Lond Engl 395:1011
doi: 10.1016/S0140-6736(20)30686-3
Attema AE L’Haridon O Raude J et al (2021) Beliefs and risk perceptions about COVID-19: evidence from two successive French representative surveys during lockdown. Front Psychol. https://doi.org/10.3389/fpsyg.2021.619145
HAS (2020) Diabète: poursuivre ses soins et faire face au COVID-19. In: Haute Aut. Santé. https://www.has-sante.fr/jcms/p_3182187/fr/diabete-poursuivre-ses-soins-et-faire-face-au-covid-19 . Accessed 26 Jul 2021
Verbruggen LC Wang Y Armenian SH et al (2020) Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: a statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.28702
Baldi E, Sechi GM, Mare C et al (2020) Out-of-hospital cardiac arrest during the Covid-19 outbreak in Italy. N Engl J Med 383:496–498
doi: 10.1056/NEJMc2010418
Kansagra AP, Goyal MS, Hamilton S, Albers GW (2020) Collateral effect of Covid-19 on stroke evaluation in the United States. N Engl J Med 383:400–401
doi: 10.1056/NEJMc2014816
Dvori M Elitzur S Barg A et al (2021) Delayed diagnosis and treatment of children with cancer during the COVID-19 pandemic. Int J Clin Oncol. https://doi.org/10.1007/s10147-021-01971-3
Atkins JL, Masoli JAH, Delgado J, Pilling LC, Kuo C-L, Kuchel GA, Melzer D (2020) Preexisting comorbidities predicting COVID-19 and mortality in the UK biobank community cohort. J Gerontol A Biol Sci Med Sci 75:2224–2230
doi: 10.1093/gerona/glaa183
Hudson MM, Ness KK, Gurney JG et al (2013) Clinical ascertainment of health outcomes among adults treated for childhood cancer: a report from the St. Jude Lifetime Cohort Study. Jama J Am Med Assoc 309:2371–2381
doi: 10.1001/jama.2013.6296
de Vathaire F, El-Fayech C, Ben Ayed FF et al (2012) Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study. Lancet Oncol 13:1002–1010
doi: 10.1016/S1470-2045(12)70323-6
Casanova M, Pagani Bagliacca E, Silva M et al (2020) How young patients with cancer perceive the COVID-19 (coronavirus) epidemic in Milan, Italy: is there room for other fears? Pediatr Blood Cancer 67:e28318
doi: 10.1002/pbc.28318
FCCSS | Le site de l’étude FCCSS.
Percy C, van Holten V, Muir CS, Organization WH (1990) International classification of diseases for oncology. World Health Organization
Haddy N, Diallo S, El-Fayech C et al (2016) Cardiac diseases following childhood cancer treatment: cohort study. Circulation 133:31–38
doi: 10.1161/CIRCULATIONAHA.115.016686
Reulen RC, Zeegers MP, Jenkinson C, Lancashire ER, Winter DL, Jenney ME, Hawkins MM (2006) The use of the SF-36 questionnaire in adult survivors of childhood cancer: evaluation of data quality, score reliability, and scaling assumptions. Health Qual Life Outcomes 4:77
doi: 10.1186/1477-7525-4-77
Ford JS, Tonorezos ES, Mertens AC et al (2020) Barriers and facilitators of risk-based health care for adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 126:619–627
doi: 10.1002/cncr.32568
Danielle WLN, Chan FHF, Barry TJ, Lam C, Chong CY, Kok HCS, Liao Q, Fielding R, Lam WWT (2020) Psychological distress during the 2019 Coronavirus Disease (COVID-19) pandemic among cancer survivors and healthy controls. Psychooncology 29:1380–1383
doi: 10.1002/pon.5437
Carreira H, Strongman H, Peppa M, McDonald HI, dos-Santos-Silva I, Stanway S, Smeeth L, Bhaskaran K (2020) Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: a matched cohort study using linked English electronic health records data. EClinicalMedicine 29–30:100656
doi: 10.1016/j.eclinm.2020.100656
Tian J, Yuan X, Xiao J et al (2020) Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol 21:893–903
doi: 10.1016/S1470-2045(20)30309-0
CDC (2020) COVID-19 and medical conditions. In: Cent. Dis. Control Prev. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fcovid-data%2Finvestigations-discovery%2Fhospitalization-underlying-medical-conditions.html . Accessed 10 Aug 2021
Chen N, Zhou M, Dong X et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet Lond Engl 395:507–513
doi: 10.1016/S0140-6736(20)30211-7
Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, Wang F (2020) Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and meta-analysis. Res Wash DC 2020:2402961
Bruine de Bruin W (2021) Age differences in COVID-19 risk perceptions and mental health: evidence from a national U.S. survey conducted in March 2020. J Gerontol Ser B 76:e24–e29
doi: 10.1093/geronb/gbaa074
Schoeni RF, Wiemers EE, Seltzer JA, Langa KM (2021) Association between risk factors for complications from COVID-19, perceived chances of infection and complications, and protective behavior in the US. Jama Netw Open 4:e213984
doi: 10.1001/jamanetworkopen.2021.3984
Forster VJ Schulte F (2020) Unique needs of childhood cancer survivors during the COVID-19 pandemic. Support Care Cancer 1–3
Kadan-Lottick NS, Robison LL, Gurney JG, Neglia JP, Yasui Y, Hayashi R, Hudson M, Greenberg M, Mertens AC (2002) Childhood cancer survivors’ knowledge about their past diagnosis and treatment: Childhood Cancer Survivor Study. Jama 287:1832–1839
doi: 10.1001/jama.287.14.1832
Chan RJ, Crichton M, Crawford-Williams F et al (2021) The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviews. Ann Oncol Off J Eur Soc Med Oncol 32:1552–1570
doi: 10.1016/j.annonc.2021.09.001
Blay JY, Boucher S, Le Vu B et al (2021) Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France. Esmo Open 6:100134
doi: 10.1016/j.esmoop.2021.100134
Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, Rachet B, Aggarwal A (2020) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 21:1023–1034
doi: 10.1016/S1470-2045(20)30388-0
ORS PACA (2020) Coconel - Note de synthèse n°9. Opinions sur le (dé)confinement et sur un vaccin contre le COVID-19, renoncement aux soins. | ORS Paca. http://www.orspaca.org/notes-strategiques/coconel-note-de-synth%C3%A8se-n%C2%B09-opinions-sur-le-d%C3%A9confinement-et-sur-un-vaccin . Accessed 28 Jul 2021
Renault-Tessier E, Carton M, Meng M-F, Milder M, Angellier E, Bouleuc C, Mino J-C (2021) Experience of care and daily life during national sanitary confinement in patients followed and treated in Cancer Control Centers: The BaroCov Inquiry. Bull Cancer (Paris) 108:481–489
doi: 10.1016/j.bulcan.2021.01.008
Miller KA Kagramanov D Cohen-Cutler S Nadim B Weng Z Gallagher P Kaslander JN Freyer DR Barzi A Lenz H-J (2021) Impacts of the SARS-CoV-2 pandemic on young adult colorectal cancer survivors. J Adolesc Young Adult Oncol. https://doi.org/10.1089/jayao.2021.0043
Wimberly CE, Towry L, Caudill C, Johnston EE, Walsh KM (2021) Impacts of COVID-19 on caregivers of childhood cancer survivors. Pediatr Blood Cancer 68:e28943
doi: 10.1002/pbc.28943
De Looper M Lafortune G (2009) Measuring disparities in health status and in access and use of health care in OECD countries.
Meshefedjian GA (2016) Association of material deprivation status, access to health care services, and lifestyle with screening and prevention of disease, Montreal, Canada, 2012. Prev Chronic Dis. https://doi.org/10.5888/pcd13.160157
Chevreul K Berg Brigham K Durand-Zaleski I Hernandez-Quevedo C (2015) France: health system review. Health Syst Transit 17:1–218, xvii
Célant N Guillaume S Thierry R (2014) Enquête sur la santé et la protection sociale 2012.
Ginsburgh V, Magerman G, Natali I (2021) COVID-19 and the role of inequality in French regional departments. Eur J Health Econ 22:311–327
doi: 10.1007/s10198-020-01254-0

Auteurs

Asmaa Janah (A)

ECEVE UMR 1123, INSERM (National Institute for Health and Medical Research, University of Paris, F-75010, Paris, France.

Charlotte Demoor-Goldschmidt (C)

University of Paris-Saclay, F-94800, Villejuif, France.
Gustave Roussy, F-94800, Villejuif, France.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800, Villejuif, France.
Pediatric Oncology Department, CHU Angers, F-49100, Angers, France.
Radiotherapy Department, François Baclesse Center, 14000, Caen, France.

Florent De Vathaire (F)

University of Paris-Saclay, F-94800, Villejuif, France. Florent.devathaire@gustaveroussy.fr.
Gustave Roussy, F-94800, Villejuif, France. Florent.devathaire@gustaveroussy.fr.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800, Villejuif, France. Florent.devathaire@gustaveroussy.fr.

Nicolas Bougas (N)

ECEVE UMR 1123, INSERM (National Institute for Health and Medical Research, University of Paris, F-75010, Paris, France.

Jacqueline Clavel (J)

Centre of Research in Epidemiology and Statistics, INSERM, Villejuif, France.
National Registry of Childhood Cancer, Paul Brousse Hospital (AP-HP), Villejuif, France.
Regional University Hospital Center of Nancy (CHRU Nancy), Vandœuvre-lès-Nancy, France.

Claire Poulalhon (C)

Centre of Research in Epidemiology and Statistics, INSERM, Villejuif, France.
National Registry of Childhood Cancer, Paul Brousse Hospital (AP-HP), Villejuif, France.
Regional University Hospital Center of Nancy (CHRU Nancy), Vandœuvre-lès-Nancy, France.

Brigitte Lacour (B)

Centre of Research in Epidemiology and Statistics, INSERM, Villejuif, France.
National Registry of Childhood Cancer, Paul Brousse Hospital (AP-HP), Villejuif, France.
Regional University Hospital Center of Nancy (CHRU Nancy), Vandœuvre-lès-Nancy, France.

Vincent Souchard (V)

University of Paris-Saclay, F-94800, Villejuif, France.
Gustave Roussy, F-94800, Villejuif, France.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800, Villejuif, France.

Angela Jackson (A)

University of Paris-Saclay, F-94800, Villejuif, France.
Gustave Roussy, F-94800, Villejuif, France.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800, Villejuif, France.

Leonie Casagranda (L)

Pediatric Oncology Department, CHU Saint-Etienne, Saint-Etienne, France.
University of Jean Monnet, INSERM, University of Lyon, U 1059, Sainbiose, France.

Claire Berger (C)

Pediatric Oncology Department, CHU Saint-Etienne, Saint-Etienne, France.
University of Jean Monnet, INSERM, University of Lyon, U 1059, Sainbiose, France.

Rodrigue Allodji (R)

University of Paris-Saclay, F-94800, Villejuif, France.
Gustave Roussy, F-94800, Villejuif, France.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800, Villejuif, France.

Nadia Haddy (N)

University of Paris-Saclay, F-94800, Villejuif, France.
Gustave Roussy, F-94800, Villejuif, France.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800, Villejuif, France.

Chiraz El Fayech (C)

University of Paris-Saclay, F-94800, Villejuif, France.
Gustave Roussy, F-94800, Villejuif, France.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800, Villejuif, France.

Brice Fresneau (B)

University of Paris-Saclay, F-94800, Villejuif, France.
Gustave Roussy, F-94800, Villejuif, France.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800, Villejuif, France.

Agnès Dumas (A)

ECEVE UMR 1123, INSERM (National Institute for Health and Medical Research, University of Paris, F-75010, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH